title: New blood: Creative funding of disease-specific research.
authors.affiliation: William E. Seaman is Research Director of the American Asthma Foundation (AAF) and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA. Corresponding author. E-mail: bseaman@medicine.ucsf.eduRichard M. Locksley is Director, Sandler Asthma Basic Research Center, University of California, San Francisco; a member of the AAF Scientific Review Board; and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.Michael J. Welsh is Chair of the AAF Scientific Review Board and a Professor in the Departments of Internal Medicine, Molecular Physiology and Biophysics, and Neurosurgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
authors.forename: William E
authors.initials: WE
authors.lastname: Seaman
authors.affiliation: William E. Seaman is Research Director of the American Asthma Foundation (AAF) and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA. Corresponding author. E-mail: bseaman@medicine.ucsf.eduRichard M. Locksley is Director, Sandler Asthma Basic Research Center, University of California, San Francisco; a member of the AAF Scientific Review Board; and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.Michael J. Welsh is Chair of the AAF Scientific Review Board and a Professor in the Departments of Internal Medicine, Molecular Physiology and Biophysics, and Neurosurgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
authors.forename: Richard M
authors.initials: RM
authors.lastname: Locksley
authors.affiliation: William E. Seaman is Research Director of the American Asthma Foundation (AAF) and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA. Corresponding author. E-mail: bseaman@medicine.ucsf.eduRichard M. Locksley is Director, Sandler Asthma Basic Research Center, University of California, San Francisco; a member of the AAF Scientific Review Board; and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.Michael J. Welsh is Chair of the AAF Scientific Review Board and a Professor in the Departments of Internal Medicine, Molecular Physiology and Biophysics, and Neurosurgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Welsh
mesh_terms: D018927:Anti-Asthmatic Agents / Q000191:economics / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000191:economics; D035843:Biomedical Research / Q000191:economics*; D003299:Cooperative Behavior; D004059:Diffusion of Innovation; D055808:Drug Discovery / Q000191:economics* / Q000458:organization & administration; D006801:Humans; D033183:Interdisciplinary Communication; D058990:Molecular Targeted Therapy / Q000191:economics; D012109:Research Support as Topic / Q000458:organization & administration
chemical_list: D018927:Anti-Asthmatic Agents